Ardelyx, Inc.
ARDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001437402
In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Ardelyx, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 189
- +29 vs. Q4 2023
- Shares held
- 141.7M
- +4.79M (+3.5%) vs. Q4 2023
- Total value
- $1.03B
- +$185.6M (+21.9%) vs. Q4 2023
- New holders
- 54
- 61 more added
- Sold out
- 25
- 56 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 250 | $906.4M |
| Q1 2026 | 242 | $1.01B |
| Q4 2025 | 229 | $972.9M |
| Q3 2025 | 223 | $891.4M |
| Q2 2025 | 206 | $657.3M |
| Q1 2025 | 221 | $808.7M |
| Q4 2024 | 213 | $765.2M |
| Q3 2024 | 203 | $982.8M |
| Q2 2024 | 197 | $1.07B |
| Q1 2024 | 189 | $1.03B |
| Q4 2023 | 161 | $849.0M |
| Q3 2023 | 150 | $513.5M |
| Q2 2023 | 146 | $426.0M |
| Q1 2023 | 130 | $550.1M |
| Q4 2022 | 104 | $225.7M |
| Q3 2022 | 83 | $79.6M |
| Q2 2022 | 78 | $22.7M |
| Q1 2022 | 89 | $42.4M |
| Q4 2021 | 100 | $46.0M |
| Q3 2021 | 108 | $66.7M |
| Q2 2021 | 127 | $643.2M |
| Q1 2021 | 125 | $559.7M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Ardelyx, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −18,683−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −17,360−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −15,093−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −13,650−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −13,612−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,976−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −11,830−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Garner Asset Management Corp | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Able Wealth Management LLC | 0 | $0 | 0.00% | −325−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Provence Wealth Management Group | – | – | – | – | Not filed |